2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
- PMID: 20872595
- DOI: 10.1002/art.27584
2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative
Abstract
Objective: The 1987 American College of Rheumatology (ACR; formerly, the American Rheumatism Association) classification criteria for rheumatoid arthritis (RA) have been criticized for their lack of sensitivity in early disease. This work was undertaken to develop new classification criteria for RA.
Methods: A joint working group from the ACR and the European League Against Rheumatism developed, in 3 phases, a new approach to classifying RA. The work focused on identifying, among patients newly presenting with undifferentiated inflammatory synovitis, factors that best discriminated between those who were and those who were not at high risk for persistent and/or erosive disease--this being the appropriate current paradigm underlying the disease construct "rheumatoid arthritis."
Results: In the new criteria set, classification as "definite RA" is based on the confirmed presence of synovitis in at least 1 joint, absence of an alternative diagnosis that better explains the synovitis, and achievement of a total score of 6 or greater (of a possible 10) from the individual scores in 4 domains: number and site of involved joints (score range 0-5), serologic abnormality (score range 0-3), elevated acute-phase response (score range 0-1), and symptom duration (2 levels; range 0-1).
Conclusion: This new classification system redefines the current paradigm of RA by focusing on features at earlier stages of disease that are associated with persistent and/or erosive disease, rather than defining the disease by its late-stage features. This will refocus attention on the important need for earlier diagnosis and institution of effective disease-suppressing therapy to prevent or minimize the occurrence of the undesirable sequelae that currently comprise the paradigm underlying the disease construct "rheumatoid arthritis."
Comment in
-
The American College of Rheumatology/European League Against Rheumatism criteria for the classification of rheumatoid arthritis: a game changer.Arthritis Rheum. 2010 Sep;62(9):2592-4. doi: 10.1002/art.27583. Arthritis Rheum. 2010. PMID: 20872597 No abstract available.
-
A perspective from India on the 2010 rheumatoid arthritis classification criteria: comment on the article by Aletaha et al.Arthritis Rheum. 2011 Feb;63(2):570; author reply 570-1. doi: 10.1002/art.30168. Arthritis Rheum. 2011. PMID: 21280013 No abstract available.
Similar articles
-
2010 rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.Ann Rheum Dis. 2010 Sep;69(9):1580-8. doi: 10.1136/ard.2010.138461. Ann Rheum Dis. 2010. PMID: 20699241
-
The 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for rheumatoid arthritis: Phase 2 methodological report.Arthritis Rheum. 2010 Sep;62(9):2582-91. doi: 10.1002/art.27580. Arthritis Rheum. 2010. PMID: 20872596 Free PMC article.
-
[Classification criteria for rheumatoid arthritis].Rev Prat. 2012 Oct;62(8):1077-80. Rev Prat. 2012. PMID: 23227602 French.
-
Comparison of the 1987 ACR and 2010 ACR/EULAR classification criteria for rheumatoid arthritis in clinical practice: a prospective cohort study.Scand J Rheumatol. 2013;42(5):362-8. doi: 10.3109/03009742.2013.776103. Epub 2013 Apr 23. Scand J Rheumatol. 2013. PMID: 23607599
-
[An important aspect of the 2010 American College of Rheumatology/European League Against Rheumatism classification criteria for the diagnosis of rheumatoid arthritis].Nihon Rinsho. 2013 Jul;71(7):1160-5. Nihon Rinsho. 2013. PMID: 23961661 Review. Japanese.
Cited by
-
Serum IL-40 increases in patients with rheumatoid arthritis and correlates with some clinical characteristics and comorbidities.Sci Rep. 2024 Nov 22;14(1):28945. doi: 10.1038/s41598-024-80104-y. Sci Rep. 2024. PMID: 39578637 Free PMC article.
-
Effectiveness and Persistence of Anti-TNFα Treatment in Patients with Rheumatoid Arthritis - A 7 Years Real-World Cohort Study.Biologics. 2024 Nov 15;18:339-347. doi: 10.2147/BTT.S474733. eCollection 2024. Biologics. 2024. PMID: 39569060 Free PMC article.
-
Current Status of Co-Ordering of C-Reactive Protein and Erythrocyte Sedimentation Rate Testing in Korea.J Korean Med Sci. 2024 Nov 18;39(44):e319. doi: 10.3346/jkms.2024.39.e319. J Korean Med Sci. 2024. PMID: 39561808 Free PMC article.
-
Fibroblast-like synoviocyte targeting antibodies are associated with failure to reach early and sustained remission or low disease activity after first-line therapy in rheumatoid arthritis.RMD Open. 2024 Nov 17;10(4):e004743. doi: 10.1136/rmdopen-2024-004743. RMD Open. 2024. PMID: 39551578 Free PMC article.
-
Cost-effectiveness analysis of Tocilizumab compared to Adalimumab in the treatment of severe active rheumatoid arthritis in Iran.Cost Eff Resour Alloc. 2024 Nov 13;22(1):82. doi: 10.1186/s12962-024-00592-7. Cost Eff Resour Alloc. 2024. PMID: 39538256 Free PMC article.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
